The survival rate of lung cancer of our country had not obviously improved in 10

The survival rate of lung cancer of our country had not obviously improved in 10
The survival rate of lung cancer of our country had not obviously improved in 10
The intersection of reporter and LiJia Yang learn at the intersection of Jiangsu Province and the intersection of Nanjing and the intersection of city and the second Meeting of national general chest surgery skill that hold from June 27 to 29: In the past 10 years, the survival rate of lung cancer of our country was not obviously improved. The surgical method may already reach limit while treating lung cancer. General thoracic surgery faces the unprecedentedly severe challenge. China cures the president of SCTE's thoracic surgeon's branch, subsidiary Beijing Friendship Hospital Professor Wang TianYou of Capital University of Medical Sciences to point out at the meeting, in the past 20 years, the mortality of lung cancer of our country has risen by 111.85%, occupy the first place in all cancers. In domestic thoracic surgery of general hospital of big city, lung cancer accounts for 60% to 80%. The treatment of lung cancer has already become main business lines of thoracic surgery at present, it is estimated the ascendant trends of its morbidity and mortality would last from 20 years to 30 at least. By 2025, the patient who dies of lung cancer will be close to 1 million every year in our country. According to 8 the intersection of centre and overth the intersection of case and statistics, area of continent, the intersection of lung cancer and person who excise for at present 70.7% ~97.8% , The mortality of operation is 0.8% ~3.1% , The operation amalgamates disease incidence 1.7% ~15% , The survival rate of 5 years after the operation is 27.2% to 40.6%. Because nearly 80% of the patients have already lost the operation opportunity while confirming lung cancer, survival rate is only 8% to 11% in 5 when lung cancer is total. Wang TianYou Professor say though lung cancer complex treatment reach common understanding already, regard as regular to launch already, but not made the survival rate of lung cancer obviously improve. He appeals for popularizing and implementing clinical norm and leadership about lung cancer in time, and combine patient's detailed conditions and treat individuals; Explore that diagnoses technology and sifts and checks the scheme in early days; The mediastinal lymph node of lung cancer of key research shifts the law, canvass the new method that the lymph node cleans; Strengthen the molecule biological study of lung cancer, introduce relevant achievements in the surgical clinical practice; Canvass electric chemotherapy, the intersection of radio frequency and the intersection of person who melt, freeze and new feasibility of method.


|